Description
Creative Biolabs offers several bioanalysis and inhibitor screening assay kits for customers, which will help researchers to accelarate the studies in immunology and onconology areas. PAD2 has been shown to modify vimentin, fibrinogen and β/γ-actin. Extracellular levels of PAD2 are increased in the lungs of smokers, providing a link between smoking as a risk factor for RA and anti-citrullinated protein antibodies among RA patients. PAD2 Inhibitor Screening Assay (Ammonia) provides a convenient method for screening human PAD2 inhibitors.
Features
Available to monitor and screen small molecular inhibitors for drug discovery and HTS applications, as well as enzyme kinetics study.
Applications
This kit is useful for screening small molecular inhibitors for drug discovery and HTS applications.
Research Areas
Immunology, Onconology
Datasheet